Skip to content

Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders

Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06512181
Acronym
U-PRESERVE
Enrollment
15
Registered
2024-07-22
Start date
2025-04-21
Completion date
2030-12-31
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Accreta Spectrum

Brief summary

This study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy. However, accumulating data show that conservative management is safer and is preferred by some patients. In selected participants (n=15) who desire uterine preservation, the investigators provide the option of conservative management, which will be defined as leaving the placenta in the uterus after delivery of the infant. This is a single-arm single-site pilot study where all participants will be carefully monitored during a standard postpartum inpatient stay and with outpatient follow-up until the uterus is empty.

Interventions

OTHERConservative/Expectant Management

At time of caesarean section, participants will not have a hysterectomy, but will be treated clinically to preserve their uterus.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. A person with a uterus, age 18 or older 4. Currently pregnant with an intrauterine gestation or postpartum 5. Suspected of having PAS based on history, clinical findings, and/or imaging 6. Patients for whom the usual management would be peripartum hysterectomy. 7. Patient desires uterine preservation or declines hysterectomy 8. Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration.

Exclusion criteria

• Have a low antenatal suspicion for PAS based on imaging.

Design outcomes

Primary

MeasureTime frameDescription
Hysterectomy rateDelivery through 1 yearPercent of participants who undergo a hysterectomy

Secondary

MeasureTime frameDescription
Endometritis rateDelivery through 1 yearPercent of participants who have endometritis
Coagulopathy rateDelivery through 1 yearPercent of participants who have coagulopathy
Frequency of vaginal bleedingDelivery through 1 yearPercent of participants with vaginal bleeding at each time point
Frequency of pelvic painDelivery through 1 yearPercent of participants with pelvic pain at each time point

Countries

United States

Contacts

CONTACTBeth Pineles, MD Phd
beth.pineles@pennmedicine.upenn.edu267-226-7933
CONTACTMeaghan McCabe, MPH
meaghan.mccabe@pennmedicine.upenn.edu
PRINCIPAL_INVESTIGATORBeth Pineles, MD PhD

University of Pennsylvania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026